Authors:
Chang, SS
Reuter, VE
Heston, WDW
Gaudin, PB
Citation: Ss. Chang et al., Comparison of anti-prostate-specific membrane antigen antibodies and otherimmunomarkers in metastatic prostate carcinoma, UROLOGY, 57(6), 2001, pp. 1179-1183
Authors:
Gong, MC
Chang, SS
Watt, F
O'Keefe, DS
Bacich, DJ
Uchida, A
Bander, NH
Reuter, VE
Gaudin, PB
Molloy, PL
Sadelian, M
Heston, WDW
Citation: Mc. Gong et al., Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy, MOL UROL, 4(3), 2000, pp. 217-222
Authors:
Chang, SS
Reuter, VE
Heston, WDW
Hutchinson, B
Grauer, LS
Gaudin, PB
Citation: Ss. Chang et al., Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues, CANCER, 88(2), 2000, pp. 407-415
Authors:
Gaudin, PB
Zelefsky, MJ
Leibel, SA
Fuks, Z
Reuter, VE
Citation: Pb. Gaudin et al., Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues, AM J SURG P, 23(9), 1999, pp. 1021-1031
Authors:
Chang, SS
Reuter, VE
Heston, WDW
Bander, NH
Grauer, LS
Gaudin, PB
Citation: Ss. Chang et al., Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature, CANCER RES, 59(13), 1999, pp. 3192-3198
Citation: Le. Harrison et al., Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection, ARCH SURG, 134(2), 1999, pp. 181-185